s6y

TAO Synergies Inc.

Ticker
TAOX
CIK
1571934
Industry
Finance Services
Formerly
Synaptogenix, Inc., NEUROTROPE BIOSCIENCE, INC.

Financials 26

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-K/A Annual Report for period ending Dec 31, 2025
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 26 financials filings

News 43

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 43 news filings

Ownership 98

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 98 ownership filings

Prospectus 27

  1. S-3/A Registration statement for specified transactions by certain issuers
  2. S-3/A Registration statement for specified transactions by certain issuers
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. S-3/A Registration statement for specified transactions by certain issuers
  5. S-3 Registration statement for specified transactions by certain issuers
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-3 Registration statement for specified transactions by certain issuers
  8. S-3 Registration statement for specified transactions by certain issuers
  9. S-3 Registration statement for specified transactions by certain issuers
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 27 prospectus filings

Proxies 18

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 18 proxies filings

Other 37

  1. EFFECT Notice of Effectiveness
  2. EFFECT Notice of Effectiveness
  3. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  4. ARS Annual report to security holders
  5. D Exempt (Private) Offering
  6. EFFECT Notice of Effectiveness
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. D Exempt (Private) Offering
  10. ARS Annual report to security holders

All 37 other filings